Advisor Group Holdings, Inc. Atri Cure, Inc. Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,350 shares of ATRC stock, worth $74,025. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,350

Previous 166 1315.66%

Holding current value

$74,025

Previous $5,000 1440.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	BUY	$29.07 - $34.94 $63,488 - $76,308	2,184 Added 1315.66%	2,350 $77,000
Q2 2025 Aug 13, 2025	SELL	$29.07 - $34.94 $185,989 - $223,546	-6,398 Reduced 97.47%	166 $5,000
Q1 2025 May 12, 2025	BUY	$30.4 - $42.4 $165,376 - $230,656	5,440 Added 483.99%	6,564 $211,000
Q4 2024 Jun 06, 2025	SELL	$27.02 - $38.2 $146,394 - $206,967	-5,418 Reduced 82.54%	1,146 $35,000
Q4 2024 Feb 07, 2025	SELL	$27.02 - $38.2 $70,224 - $99,281	-2,599 Reduced 69.81%	1,124 $34,000
Q3 2024 Nov 13, 2024	SELL	$20.34 - $29.5 $5,857 - $8,496	-288 Reduced 7.18%	3,723 $104,000
Q2 2024 Aug 13, 2024	SELL	$19.86 - $29.09 $70,800 - $103,705	-3,565 Reduced 47.06%	4,011 $91,000
Q1 2024 May 10, 2024	SELL	$28.21 - $37.78 $213,944 - $286,523	-7,584 Reduced 50.03%	7,576 $230,000
Q4 2023 Feb 12, 2024	SELL	$32.99 - $43.25 $30,317 - $39,746	-919 Reduced 5.72%	15,160 $541,000
Q3 2023 Nov 13, 2023	BUY	$41.12 - $57.73 $96,632 - $135,665	2,350 Added 17.12%	16,079 $704,000
Q2 2023 Aug 10, 2023	BUY	$40.44 - $49.6 $4,286 - $5,257	106 Added 0.78%	13,729 $677,000
Q1 2023 May 12, 2023	BUY	$35.87 - $47.22 $68,798 - $90,567	1,918 Added 16.39%	13,623 $564,000
Q4 2022 Feb 10, 2023	SELL	$33.48 - $47.45 $9,006 - $12,764	-269 Reduced 2.25%	11,705 $519,000
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $15,300 - $21,048	400 Added 3.46%	11,974 $469,000
Q2 2022 Aug 10, 2022	SELL	$35.1 - $66.01 $16,321 - $30,694	-465 Reduced 3.86%	11,574 $473,000
Q1 2022 May 04, 2022	BUY	$57.43 - $71.39 $19,353 - $24,058	337 Added 2.88%	12,039 $790,000
Q3 2021 Nov 05, 2021	SELL	$69.28 - $84.46 $1.31 Million - $1.6 Million	-18,934 Reduced 61.8%	11,702 $814,000
Q2 2021 Aug 02, 2021	BUY	$64.13 - $80.18 $1.27 Million - $1.59 Million	19,854 Added 184.14%	30,636 $2.43 Million
Q1 2021 May 13, 2021	BUY	$53.79 - $66.98 $153,570 - $191,227	2,855 Added 36.02%	10,782 $706,000
Q4 2020 Feb 10, 2021	BUY	$34.56 - $57.55 $19,319 - $32,170	559 Added 7.59%	7,927 $441,000
Q3 2020 Nov 12, 2020	BUY	$38.36 - $46.91 $30,035 - $36,730	783 Added 11.89%	7,368 $294,000
Q2 2020 Aug 14, 2020	BUY	$31.78 - $51.19 $26,599 - $42,846	837 Added 14.56%	6,585 $295,000
Q1 2020 May 18, 2020	BUY	$24.49 - $43.84 $140,768 - $251,992	5,748 New	5,748 $193,000

Others Institutions Holding ATRC

# of Institutions

225

Shares Held

52.2M

Call Options Held

33.5K

Put Options Held

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.46B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Atri Cure, Inc. Transaction History